Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Chromosome Res ; 17(1): 19-36, 2009.
Article in English | MEDLINE | ID: mdl-19190990

ABSTRACT

Drosophila melanogaster HP1-interacting protein (Hip) is a partner of heterochromatin protein 1 (HP1) and is involved in transcriptional epigenetic gene silencing and the formation of heterochromatin. Recently, it has been shown that HP1 interacts with the telomere capping factor HP1/ORC (origin recognition complex)-associated protein (HOAP). Telomeres, complexes of DNA and proteins at the end of linear chromosomes, have been recognized to protect chromosome ends from degradation and fusion events. Both proteins are located at telomeres and prevent telomere fusions. Here, we report the identification and characterization of the Hip-interacting protein Umbrea. We found that Umbrea interacts directly with Hip, HP1 and HOAP in vitro. Umbrea, Hip and HP1 are partners in a protein complex in vivo and completely co-localize in the pericentric heterochromatin and at telomeres. Using a Gal4-induced RNA interference system, we found that after depletion of Umbrea in salivary gland polytene chromosomes, they exhibit multiple telomeric fusions. Taken together, these results suggest that Umbrea cooperates with Hip, HP1 and HOAP and plays a functional role in mediating normal telomere behaviour in Drosophila.


Subject(s)
Chromosomal Proteins, Non-Histone/metabolism , Drosophila Proteins/metabolism , Drosophila melanogaster/metabolism , Heterochromatin/metabolism , Amino Acid Sequence , Animals , Chromosomal Proteins, Non-Histone/analysis , Chromosomal Proteins, Non-Histone/genetics , Chromosomes/metabolism , Chromosomes/ultrastructure , Drosophila Proteins/analysis , Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Immunoblotting , Models, Genetic , Molecular Sequence Data , Mutation , Telomere/metabolism
2.
Proc Natl Acad Sci U S A ; 105(46): 17807-11, 2008 Nov 18.
Article in English | MEDLINE | ID: mdl-19004802

ABSTRACT

The glucose analogue 2-deoxy-D-glucose (2-DG) restrains growth of normal and malignant cells, prolongs the lifespan of C. elegans, and is widely used as a glycolytic inhibitor to study metabolic activity with regard to cancer, neurodegeneration, calorie restriction, and aging. Here, we report that separating glycolysis and the pentose phosphate pathway highly increases cellular tolerance to 2-DG. This finding indicates that 2-DG does not block cell growth solely by preventing glucose catabolism. In addition, 2-DG provoked similar concentration changes of sugar-phosphate intermediates in wild-type and 2-DG-resistant yeast strains and in human primary fibroblasts. Finally, a genome-wide analysis revealed 19 2-DG-resistant yeast knockouts of genes implicated in carbohydrate metabolism and mitochondrial homeostasis, as well as ribosome biogenesis, mRNA decay, transcriptional regulation, and cell cycle. Thus, processes beyond the metabolic block are essential for the biological properties of 2-DG.


Subject(s)
Deoxyglucose/pharmacology , Eukaryotic Cells/cytology , Eukaryotic Cells/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Eukaryotic Cells/metabolism , Fibroblasts/cytology , Fibroblasts/drug effects , Glycolysis/drug effects , Humans , Pentose Phosphate Pathway/drug effects , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...